Ascendis Pharma (ASND1N) Q2 2023 Earnings Report

0 Followers

MX:ASND1N Upcoming Earnings

Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:ASND1N earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 17, 2027	2026 (Q4)	31.62-	-11.31	―	―
Nov 12, 2026	2026 (Q3)	16.2222.20	-20.56	208.00% (+42.76)
Aug 13, 2026	2026 (Q2)	30.7758.17	-16.86	445.12% (+75.03)
May 07, 2026	2026 (Q1)	―200.42	-32.48	717.09% (+232.90)
Feb 11, 2026	2025 (Q4)	-1.64-11.31	-13.16	14.06% (+1.85)
Nov 12, 2025	2025 (Q3)	-5.02-20.56	-35.36	41.86% (+14.80)
Aug 07, 2025	2025 (Q2)	-26.44-16.86	-39.26	57.07% (+22.41)
May 01, 2025	2025 (Q1)	-30.16-32.48	-47.28	31.30% (+14.80)
Feb 12, 2025	2024 (Q4)	-20.23-13.16	-31.66	58.44% (+18.50)
Nov 14, 2024	2024 (Q3)	-32.17-35.36	-55.3	36.06% (+19.94)
Sep 03, 2024	2024 (Q2)	-29.97-39.26	-44.4	11.57% (+5.14)
May 02, 2024	2024 (Q1)	-30.36-47.28	-40.7	-16.16% (-6.58)
Feb 07, 2024	2023 (Q4)	-37.31-31.66	-76.06	58.38% (+44.40)
Nov 07, 2023	2023 (Q3)	-48.78-55.30	-63.83	13.37% (+8.53)
Sep 05, 2023	2023 (Q2)	-51.86-44.40	-30.01	-47.95% (-14.39)
Apr 27, 2023	2023 (Q1)	-54.64-40.70	-45.43	10.41% (+4.73)
Feb 16, 2023	2022 (Q4)	-54.47-76.06	-38.23	-98.92% (-37.82)
Nov 02, 2022	2022 (Q3)	-47.27-63.83	-30.22	-111.22% (-33.61)
Aug 10, 2022	2022 (Q2)	-40.23-30.01	-51.39	41.60% (+21.38)
May 11, 2022	2022 (Q1)	―-45.43	-24.05	-88.89% (-21.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed